MEDVi vs Zealthy: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats Zealthy overall, scoring 7.7/10 vs 7.2/10. Zealthy is more affordable at $286/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Zealthy for users who want the option to switch between compounded and b.

A side-by-side comparison of MEDVi and Zealthy covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Zealthy

#42 of 48

7.2/10

Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.

Visit Zealthy

Feature	MEDVi	Zealthy
Our Score	7.7/10	7.2/10
Starting Price	$299/mo	$286/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Users who want the option to switch between compounded and brand-name GLP-1s
Ranking	#22	#42

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Zealthy

Pros

+Dedicated insurance coordinators handle prior authorizations — potentially bringing brand-name GLP-1 costs to $25/mo
+Multi-month supply options (3, 6, or 12 months) — unique convenience most monthly-shipping competitors can't match
+Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
+LegitScript certified with 4.5-star Review.io rating

Cons

−$135 membership fee on top of medication cost makes cash-pay total ~$286/mo for semaglutide — above average
−Young company (founded 2023) with a relatively small review base — less track record than established platforms
−Prescription products are non-refundable for any reason once ordered

Our Verdict

MEDVi edges out Zealthy with a score of 7.7/10 vs 7.2/10. If budget is your priority, Zealthy starts at $286/mo compared to MEDVi's $299/mo. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Zealthy if you want: users who want the option to switch between compounded and brand-name glp-1s.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MEDVi nor Zealthy feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review